Related Experiment Video
Updated: Jun 8, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
YB1 and its role in osteosarcoma: a review
1Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Abstract:
YB1 (Y box binding protein 1), a multifunctional protein capable of binding to DNA/RNA, is present in most cells and acts as a splicing factor. It is involved in numerous cellular processes such as transcription, translation, and DNA repair, significantly affecting cell proliferation, differentiation, and apoptosis. Abnormal expression of this protein is closely linked to the formation of various malignancies (osteosarcoma, nasopharyngeal carcinoma, breast cancer, etc.). This review examines the multifaceted functions of YB1 and its critical role in osteosarcoma progression, providing new perspectives for potential therapeutic strategies.
Insights
Y box binding protein 1 (YB1) is crucial for cell processes and cancer. This review highlights YB1's role in osteosarcoma, offering insights for new cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Y box binding protein 1 (YB1) is a multifunctional DNA/RNA-binding protein involved in fundamental cellular processes.
- YB1 regulates transcription, translation, DNA repair, proliferation, differentiation, and apoptosis.
- Aberrant YB1 expression is implicated in various cancers, including osteosarcoma.
Purpose of the Study:
- To review the diverse functions of YB1.
- To elucidate the critical role of YB1 in osteosarcoma progression.
- To explore potential therapeutic strategies targeting YB1 in osteosarcoma.
Main Methods:
- Literature review of YB1 functions and its involvement in cancer.
- Analysis of studies focusing on YB1's role in osteosarcoma development and progression.
- Synthesis of current knowledge on YB1-targeting therapeutic approaches.
Main Results:
- YB1 participates in multiple cellular mechanisms vital for cell survival and function.
- Evidence demonstrates YB1's significant contribution to osteosarcoma initiation and advancement.
- Dysregulation of YB1 is a common feature in osteosarcoma.
Conclusions:
- YB1 is a key player in cellular regulation and oncogenesis.
- Targeting YB1 presents a promising avenue for novel osteosarcoma treatments.
- Further research into YB1's mechanisms may unlock innovative therapeutic strategies.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Bone Formation by Endochondral Ossification
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
Abnormal Proliferation

